Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.

Saved in:
Bibliographic Details
Title: Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.
Authors: Modi, S.1 modis@mskcc.org, Jacot, W.2, Yamashita, T.3, Sohn, J.4, Vidal, M.5, Tokunaga, E.6, Tsurutani, J.7, Ueno, N. T.8, Prat, A.5,9,10,11, Chae, Y. S.12, Lee, K. S.13, Niikura, N.14, Park, Y. H.15, Xu, B.16, Wang, X.17, Gil-Gil, M.18, Li, W.19, Pierga, J.-Y.20, Im, S.-A.21, Moore, H. C. F.22
Source: New England Journal of Medicine. 7/7/2022, Vol. 387 Issue 1, p9-20. 12p.
Database: Academic Search Ultimate
Description
ISSN:00284793
DOI:10.1056/NEJMoa2203690